Open AccessSuccessful Treatment of a Patient With Epstein-Barr Virus–Positive B-Cell Lymphoproliferative Disorder Resembling Post-Transplant Lymphoproliferative Disorder Using Single-Agent Rituximab
Author(s) -
Norman I Maldonado,
Fernando Cabanillas,
Elaine S. Jaffe,
Mark Raffeld,
Luis Lozada
Publication year - 2011
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2011.34.8656
Subject(s) - rituximab , lymphoproliferative disorders , medicine , post transplant lymphoproliferative disorder , lymphoma , epstein–barr virus , immunology , cd20 , transplantation , monoclonal , virus , antibody , monoclonal antibody
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom